Applied BioCode

Applied BioCode AAQS

O O AAQS de Applied BioCode (6598.TW) em 14 de out. de 2026 é 6. No ano anterior, O AAQS foi 6,00 — uma variação de 0,00% (inferior).

AAQS

6

YoY

0,00%

Última atualização:

Applied BioCode tem um AAQS atual de 6.

Um alto AAQS pode ser considerado um indicativo positivo de que a empresa está se desenvolvendo com sucesso.

Os investidores podem assumir que a empresa está no caminho certo para obter lucros.

Por outro lado, é importante considerar o AAQS da ação Applied BioCode em comparação aos lucros obtidos e a outras empresas do mesmo setor. Um alto AAQS não é uma garantia absoluta de um futuro positivo. Apenas desta maneira, é possível obter uma imagem completa do desempenho da empresa.

Para melhor avaliar o desenvolvimento da empresa, é importante comparar o AAQS com outras empresas do mesmo setor. Em geral, os investidores devem sempre considerar o AAQS de uma empresa em conjunto com outros indicadores, como lucro, EBIT, fluxo de caixa e outros, para fazer uma decisão de investimento fundamentada.

A Applied BioCode AAQS História

  • 3 anos

  • 10 anos

  • 25 anos

  • Max

AAQS
Data
AAQS
1 de jan. de 2018
6,00 TWD
1 de jan. de 2019
6,00 TWD
1 de jan. de 2020
6,00 TWD
1 de jan. de 2021
6,00 TWD
1 de jan. de 2022
6,00 TWD
1 de jan. de 2023
6,00 TWD
1 de jan. de 2024
6,00 TWD
1 de jan. de 2025
6,00 TWD
A Applied BioCode AAQS História
ANOAAQSYoY
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
60,00%
6—
Aceda a estes dados via API Eulerpool

Applied BioCode Análise de ações

O que Applied BioCode faz? Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode é uma das empresas mais populares na Eulerpool.com.

Perguntas frequentes sobre ação Applied BioCode

O AAQS de Applied BioCode é 6 em 2025.

Na Eulerpool você encontra o histórico completo do Applied BioCode de O AAQS desde 2006, com valores anuais, gráficos e análises detalhadas.

O AAQS é um indicador desenvolvido pela AlleAktien.

O AAQS é um indicador desenvolvido pela AlleAktien.

Aceda a estes dados via API Eulerpool

Qualidade — Applied BioCode

Todas as Métricas Financeiras — Applied BioCode